Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Teva
Deloitte
Argus Health
Federal Trade Commission
UBS
Harvard Business School
Colorcon
Mallinckrodt

Generated: October 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 021077

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0695-001 INHALER in 1 CARTON (0173-0695-00) > 60 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0695-041 INHALER in 1 CARTON (0173-0695-04) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0695-611 INHALER in 1 CARTON (0173-0695-61) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0696-001 INHALER in 1 CARTON (0173-0696-00) > 60 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0696-041 INHALER in 1 CARTON (0173-0696-04) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0696-611 INHALER in 1 CARTON (0173-0696-61) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0697-001 INHALER in 1 CARTON (0173-0697-00) > 60 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0697-041 INHALER in 1 CARTON (0173-0697-04) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDAGlaxoSmithKline LLC0173-0697-611 INHALER in 1 CARTON (0173-0697-61) > 14 POWDER in 1 INHALER
Glaxo Grp Ltd
ADVAIR DISKUS 100/50
fluticasone propionate; salmeterol xinafoate
POWDER;INHALATION021077NDARebel Distributors Corp.21695-196-0160 POWDER in 1 INHALER (21695-196-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
McKinsey
US Army
Fish and Richardson
Accenture
Medtronic
Colorcon
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot